Welcome to our dedicated page for MEDLINE news (Ticker: MDLN), a resource for investors and traders seeking the latest updates and insights on MEDLINE stock.
Medline Inc. (Nasdaq: MDLN) is a healthcare company focused on medical-surgical ("med-surg") products and supply chain solutions that serve hospitals, surgery centers, physician offices and post-acute care facilities. The Medline news page on Stock Titan highlights company announcements that explain how it operates as what it describes as the largest provider of med-surg products and supply chain solutions serving all points of care, based on total net sales of med-surg products.
News related to Medline often centers on capital markets activity and corporate milestones, such as the public filing of its registration statement on Form S-1 with the U.S. Securities and Exchange Commission, the pricing of its upsized initial public offering of Class A common stock, and the closing of that upsized offering on the Nasdaq Global Select Market under the symbol MDLN. These updates provide context on Medline’s transition to being a publicly traded company and its use of offering proceeds for debt repayment, general corporate purposes and transactions with pre-IPO owners.
Investors and observers can also find Medline announcements about participation in major healthcare and investor conferences, such as the J.P. Morgan Healthcare Conference. Such events can offer additional insight into how the company presents its med-surg product portfolio, supply chain capabilities and clinical solutions to the investment community.
This news page aggregates these types of press releases and corporate communications so readers can review Medline’s official statements over time. For anyone tracking MDLN, the page offers a focused view of the company’s own disclosures about its business focus, public listing, capital structure and engagement with the broader healthcare and financial markets.
Medline (Nasdaq: MDLN) announced its first Prime Vendor agreement outside the U.S., signed by Medline Canada with Mohawk Medbuy, one of Canada's largest healthcare procurement groups. The deal covers warehouse and supply chain logistics for selected hospitals in Southwestern Ontario.
Beginning this fall, Medline Canada will implement a stockless distribution model, delivering customized low-unit quantities directly to care sites. Through its Supply Chain Solutions division, it will also provide delivery and storage optimization, automatic substitutions, backorder management with national brands, and data-driven tools to strengthen supply chain resiliency.
Medline (Nasdaq: MDLN) closed an upsized secondary offering of 72,554,594 Class A shares, sold by stockholders affiliated with Blackstone, Hellman & Friedman and Abu Dhabi Investment Authority at $37.00 per share.
The selling holders granted underwriters a 30-day option for up to 10,883,189 additional shares. Medline sold no shares and receives no proceeds.
Medline (Nasdaq: MDLN) announced upcoming investor conference participation by its executive leadership team.
CFO Mike Drazin and CPO Amanda Laabs will present at the William Blair 46th Annual Growth Stock Conference on June 3, 2026, while CEO Jim Boyle and CFO Mike Drazin will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. Live webcasts and 90-day replays will be available on Medline’s investor relations Events page.
Medline (Nasdaq: MDLN) priced an upsized secondary offering of 72,554,594 Class A shares by selling stockholders at $37.00 per share. Underwriters have a 30-day option for up to 10,883,189 additional shares. The offering should close on May 28, 2026, and Medline will not receive proceeds.
Medline (Nasdaq: MDLN) expanded its animal health portfolio with custom spay/neuter surgical packs for shelters, high‑volume clinics and veterinary practices. The ready-to-use packs group sterile instruments to streamline procedures, reduce prep time and support higher surgical throughput, aiming to ease staff burden and improve access to spay/neuter services.
Medline (Nasdaq: MDLN) announced a secondary offering of Class A common stock by certain selling stockholders affiliated with Blackstone, Hellman & Friedman and Abu Dhabi Investment Authority.
The underwritten public offering covers 60,000,000 shares, with a 30-day option for underwriters to buy up to 9,000,000 additional shares. Medline is not selling shares and will not receive proceeds.
Medline (Nasdaq: MDLN) deployed a new AutoStore automated storage and retrieval system at its Aurora, Colorado distribution center, its 24th AutoStore installation in the U.S.
The system includes eight induction workstations, 10 picking workstations, 38,000 bins and 96 robots, aiming to boost scalability and fulfillment efficiency.
Medline (Nasdaq: MDLN) reported Q1 2026 results: net sales $7.4B (+10.7%), net income $239M (-25.8%), and Adjusted EBITDA $776M (-10.6%).
The company raised full‑year Organic Sales guidance to 8.5%–9.5% and maintained Adjusted EBITDA guidance of $3.5B–$3.6B.
Medline (Nasdaq: MDLN) launched Mpower on May 4, 2026: a cloud-based, AI-powered digital control tower for healthcare supply chains built with Microsoft. Early deployment with 10 U.S. health systems produced >50% efficiency gains in order substitution workflows and 1–2% higher unadjusted fill-rates. Mpower integrates Medline supply and demand data, includes an AI chat agent, leverages Microsoft Azure and Office 365, and will roll out in phases throughout 2026 with additional capabilities planned.
Medline (Nasdaq: MDLN) announced a strategic agreement to pilot the Symbotic System, an AI-enabled robotics warehouse automation platform, at one of its 45 U.S. distribution centers in 2027. The pilot marks Medline's first deployment of this technology in healthcare to boost speed, accuracy, scalability and employee safety.
The Symbotic System automates depalletizing, singulation, storage/retrieval and smart outbound pallet building to modernize fulfillment across Medline's vertically integrated supply chain.